🔗 Permalink

Inventor profile of:

Avinash Phadke

City:

Branford, Connecticut

Country:

United States

Published Applications:

Last publication date:

2023-03-30

Top Assignees for applications by Avinash Phadke

The entities that hold a legal rights for patent applications filed by inventor Phadke Avinash:

Achillion Pharmaceuticals Inc. 50 New Haven, CT United States
Achillion Pharmaceuticals, Inc. 3 Blue Bell, PA United States
JANSSEN PHARMACEUTICALS, INC. 3 Titusville, NJ United States
Achillion Pharmaceuticals, Inc. 3 Boston, MA United States
ACHILLION PHARMACEUTICALS 2 New Haven, CT United States
Achillon Pharmaceuticals, Inc. 1 Boston, MA United States

Recent patent applications by Phadke Avinash

Avinash Phadke from Branford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-03-30

US20230094124A1

Chemistry; metallurgy

Morphic forms of danicopan

#2 | 2022-04-21

US20220119400A1

Chemistry; metallurgy

QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS

#3 | 2021-10-28

US20210332026A1

Chemistry; metallurgy

Morphic forms of complement factor D inhibitors

#4 | 2020-05-28

US20200165262A1

Chemistry; metallurgy

Quinazoline and indole compounds to treat medical disorders

#5 | 2019-05-16

US20190144473A1

Chemistry; metallurgy

Amino compounds for treatment of complement mediated disorders

#6 | 2019-05-09

US20190135825A1

Chemistry; metallurgy

Quinazoline and indole compounds to treat medical disorders

#7 | 2019-03-21

US20190085005A1

Chemistry; metallurgy

Phosphonate compounds for treatment of complement mediated disorders

#8 | 2018-10-25

US20180303800A1

Human necessities

SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS

#9 | 2018-03-01

US20180055824A1

Human necessities

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections

#10 | 2018-01-25

US20180021361A1

Human necessities

COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION

#11 | 2018-01-25

US20180021360A1

Human necessities

Combination Therapy Regimen For Treatment Of Selected HCV Genotypes

#12 | 2017-11-09

US20170319572A1

Human necessities

COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION

#13 | 2017-09-14

US20170260219A1

Chemistry; metallurgy

Phosphonate compounds for treatment of complement mediated disorders

#14 | 2017-06-08

US20170157096A1

Human necessities

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#15 | 2017-03-30

US20170087174A1

Human necessities

COMBINATION THERAPY REGIMEN FOR TREATMENT OF HCV

#16 | 2017-01-12

US20170007579A1

Human necessities

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#17 | 2016-06-23

US20160176847A1

Chemistry; metallurgy

Sovaprevir polymorphs and methods of manufacture thereof

#18 | 2016-04-28

US20160115157A1

Chemistry; metallurgy

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#19 | 2016-04-28

US20160113907A1

Human necessities

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#20 | 2016-03-24

US20160082069A1

Human necessities

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#21 | 2016-01-21

US20160016986A1

Chemistry; metallurgy

STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENT

#22 | 2015-11-12

US20150322109A1

Chemistry; metallurgy

Process for producing Sovaprevir

#23 | 2015-09-08

US13105504

Human necessities

Biphenyl imidazoles and related compounds useful for treating HCV infections

#24 | 2014-11-06

US20140328796A1

Human necessities

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#25 | 2014-10-30

US20140323458A1

Chemistry; metallurgy

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#26 | 2014-10-16

US20140309189A1

Chemistry; metallurgy

Highly active nucleoside derivative for the treatment of HCV

#27 | 2014-10-16

US20140309164A1

Chemistry; metallurgy

DEUTERATED NUCLEOSIDE PRODRUGS USEFUL FOR TREATING HCV

#28 | 2014-09-18

US20140275520A1

Chemistry; metallurgy

Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof

#29 | 2014-09-18

US20140275480A1

Chemistry; metallurgy

Processes for Producing sovaprevir

#30 | 2014-09-18

US20140275163A1

Chemistry; metallurgy

Sovaprevir polymorphs and methods of manufacture thereof

#31 | 2014-09-18

US20140274914A1

Chemistry; metallurgy

ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof

#32 | 2014-09-18

US20140271855A1

Human necessities

SOVAPREVIR TABLETS

#33 | 2014-09-16

US13423935

NS5A inhibitors useful for treating HCV

#34 | 2014-07-24

US20140206604A1

Chemistry; metallurgy

4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATION

#35 | 2014-04-24

US20140113890A1

Chemistry; metallurgy

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#36 | 2013-06-27

US20130165471A1

Chemistry; metallurgy

2-SUBSTITUTED-THIENOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS

#37 | 2012-11-29

US20120302538A1

Human necessities

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#38 | 2012-05-03

US20120108576A1

Chemistry; metallurgy

THIAZOLE COMPOUNDS AND METHODS OF USE

#39 | 2011-03-24

US20110070168A1

Human necessities

Macrocyclic peptides as inhibitors of viral replication

#40 | 2010-11-18

US20100292219A1

Chemistry; metallurgy

Tertiary amine substituted peptides useful as inhibitors of HCV replication

#41 | 2010-10-07

US20100256112A1

Human necessities

Hydroxylthienoquinolones and related compounds as anti-infective agents

#42 | 2010-08-26

US20100216725A1

Chemistry; metallurgy

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#43 | 2010-06-17

US20100152103A1

Chemistry; metallurgy

4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication

#44 | 2010-05-20

US20100124545A1

Chemistry; metallurgy

Cyclic carboxamide compounds and analogues thereof as of hepatitis C virus

#45 | 2010-02-04

US20100029652A1

Human necessities

Combination Therapy For Treating Hepatitis C Infections

#46 | 2009-12-10

US20090304605A1

Chemistry; metallurgy

Substituted aminothiazole prodrugs of compounds with anti-HCV activity

#47 | 2009-03-26

US20090082261A1

Chemistry; metallurgy

Urea-containing peptides as inhibitors of viral replication

#48 | 2009-02-19

US20090048297A1

Human necessities

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#49 | 2009-02-12

US20090041720A1

Chemistry; metallurgy

Heteroaryl substituted thiazoles

#50 | 2009-01-22

US20090023730A1

Chemistry; metallurgy

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

#51 | 2007-09-13

US20070213301A1

Chemistry; metallurgy

Substituted Aminothiazole Derivatives With Anti-HCV Activity

#52 | 2007-01-04

US20070004711A1

Chemistry; metallurgy

Thiazole compounds and methods of use

#53 | 2006-08-22

US10716175

Substituted aryl thioureas and related compounds; inhibitors of viral replication

#54 | 2006-02-02

US20060025416A1

Chemistry; metallurgy

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

#55 | 2006-01-19

US20060014836A1

Chemistry; metallurgy

Substituted aryl thioureas and related compounds; inhibitors of viral replication

#56 | 2005-10-13

US20050228013A1

Human necessities

Azabenzofuran substituted thioureas; inhibitors of viral replication

#57 | 2005-02-10

US20050032849A1

Chemistry; metallurgy

Substituted arylthiourea derivatives useful as inhibitors of viral replication

#58 | 2005-01-27

US20050020559A1

Chemistry; metallurgy

Chlorin photosensitizing agents for use in photodynamic therapy

InventorID:

313698 ⎘